-
Mashup Score: 4Researchers link death in gene-editing study to a virus used to deliver the treatment, not CRISPR - 11 month(s) ago
The lone volunteer in a gene-editing study targeting a rare form of Duchenne muscular dystrophy likely died after having a reaction to the virus that delivered the therapy in his body, researchers concluded in an early study.
Source: medicalxpress.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1Q&A: We must ‘outsmart the virus’: Strategy needed to curb risk for long COVID, GI issues - 1 year(s) ago
Infection with SARS-CoV-2 increased the risk for long-term gastrointestinal problems within 1 year, including motility disorders, acute pancreatitis and liver disease, according to a study published in Nature Communications.“There are a lot of different hypotheses to explain why SARS-CoV-2, which we all thought of as a respiratory virus that leads to pneumonia or other respiratory problems,
Source: www.healio.comCategories: Gastroenterology, Latest HeadlinesTweet-
#ICYMI: "We need to outsmart the #virus with a long-term sustainable strategy. We need a #vaccine approach that reduces or blocks transmission, is more durable and is variant proof," @zalaly, told @GoHealio #GI. @NatureComms #GITwitter #COVID19 https://t.co/ccZns5Bb59
-
-
Mashup Score: 0Sudan Ebola virus (SUDV) outbreak in Uganda, 2022: lessons learnt and future priorities for sub-Saharan Africa - BMC Medicine - 1 year(s) ago
BMC Medicine volume 21, Article number: 144 (2023) Cite this article Background On 20th September 2022, the Ugandan Ministry…
Source: BioMed CentralCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
In this Commentary, Godfrey Bwire and colleagues call for action to invest in critical areas to rapidly prevent, mitigate and respond to future Sudan #Ebola #virus outbreaks in sub-Saharan #Africa @MinofHealthUG @MakSPH - read the full story here: https://t.co/tSFk9pDVI2 https://t.co/tngLNCS4yP
-
-
Mashup Score: 0
Background The immune response to infections could be largely driven by the individual’s genes, especially in the major histocompatibility complex (MHC) region. Varicella-zoster virus (VZV) is a highly communicable pathogen. In addition to infection, the reactivations of VZV can be a potential causal factor for multiple traits. Identification of VZV immune response-related health conditions can…
Source: BioMed CentralCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
This phenome-wide Mendelian randomization study by Xinzhu Yu and colleagues @OfficialUoM @FBMH_UoM explores the causal role of the immune response to the varicella-zoster #virus on multiple traits. Read the full story here: https://t.co/BXwmB8zRNo https://t.co/tLHKU1ij2y
-
-
Mashup Score: 1Opinion | Do We Need a Spring COVID-19 Booster? - 1 year(s) ago
A look at the data, particularly for high-risk groups
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Is a #COVID19booster necessary for the spring season? 🌷 In this #OpEd, @jeremyfaust & @dr_kkjetelina share that if you're #immunocompromised and/or an older adult with a #comorbidity, a spring booster may be a good idea to stay ahead of the #virus. https://t.co/hE0DUTX759
-
-
Mashup Score: 2
A new analysis of genetic samples from China appears to link the pandemic’s origin to raccoon dogs.
Source: apple.newsCategories: Healthcare Professionals, Latest HeadlinesTweet-
“analysis of genetic sequences collected from the market shows that raccoon dogs being illegally sold at the venue could have been carrying & possibly shedding the #virus at the end of 2019.” thank you to all virologists/biologists involved! https://t.co/qyAXMiGQwZ
-
-
Mashup Score: 2Scientists have revived a 'zombie' virus that spent 48,500 years frozen in permafrost | CNN - 1 year(s) ago
Warmer temperatures in the Arctic are thawing the region’s permafrost — a frozen layer of soil beneath the ground — and potentially stirring viruses that, after lying dormant for tens of thousands of years, could endanger animal and human health.
Source: CNNCategories: Cardiologists, Latest HeadlinesTweet-
RT @GenomeScience: #virus #ClimateChange #ClimateMedicine #ScienceTwitter Check out this article: https://t.co/pkkQpB4SnG
-
-
Mashup Score: 0
Show This Week in Virology, Ep Clinical update with Dr. Daniel Griffin – Mar 3, 2023
Source: Apple PodcastsCategories: Latest Headlines, PediatricsTweet-
Great clinical update on TWiV…norovirus, RSV vaccine, and COVID19 information…😊👍 #norovirus #RSV #covid19 #virus #vaccines @ThisIsOurShot @VacunateYa @Voices4Vaccines @DrPanMD @PedsMamaDoc @PeterHotez @healthychildren https://t.co/ue5MAAzIUh
-
-
Mashup Score: 6New compound inhibits influenza virus replication - 1 year(s) ago
Viruses use the molecular repertoire of the host cell to replicate. Researchers from the Cluster of Excellence ImmunoSensation2 at the University of Bonn, together with Japanese researchers, want to exploit this for the treatment of influenza.
Source: medicalxpress.comCategories: General Medicine News, Latest HeadlinesTweet-
New compound inhibits #influenza #virus replication @sciencemagazine https://t.co/hj6ODzlvAx
-
-
Mashup Score: 1Marburg vaccine shows promising results in first-in-human study - 1 year(s) ago
A newly published paper in The Lancet shows that an experimental vaccine against Marburg virus (MARV) was safe and induced an immune response in a small, first-in-human clinical trial. The vaccine, developed by researchers at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, could someday be an important tool to respond to Marburg virus…
Source: EurekAlert!Categories: General Medicine News, Latest HeadlinesTweet-
A study shows that an experimental #vaccine against #Marburg #virus (#MARV) was safe and induced an immune response in a small, first-in-human clinical trial; The vaccine could someday be an important tool to respond to Marburg virus outbreaks @NIAIDNews https://t.co/UtzJwSB1KS
-
Researchers link death in gene-editing study to a #virus used to deliver the treatment, not CRISPR https://t.co/GnJ2RNBeCd